Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

The Outlook of Aurora Stock Is Mixed

By Chris Lau, InvestorPlace Contributor

Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.

7 Hot Payments Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor

Payment stocks continue to roar higher. It is not too late to catch them as electronic transactions grow for years to come.

Teva Pharmaceuticals Stock Is Safe With Settlement Talks Underway

By Chris Lau, InvestorPlace Contributor

Despite the rally, Teva stock is inexpensive. The company is working on paying off its debt and building a strong generics portfolio.

What It Will Take for AMZN Stock to Breakout Above $1,800?      

By Chris Lau, InvestorPlace Contributor

Black Friday and Cyber Monday are obvious positive catalysts for AMZN stock. What else will send the shares higher?

Here’s How Red-Hot Advanced Micro Devices Stock Just Got Hotter

By Chris Lau, InvestorPlace Contributor

Advanced Micro Devices stock is a 2019 winner. Its new GPU product and server chip solution is a clear success story.

Load More